EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudie

Synergistic predictive value of T-stage and lymph node yield in guiding adjuvant radiotherapy decisions for pN1 OSCC without high-risk features: a multi-institutional retrospective cohort study

Bo Li, Yu Huang, Hanchen Zhou, Chuanbin Guo, Wei Wei, Wei Cao, Zhien Feng

Clinical Oral Investigations · 02.05.2026 · 30 (5)

DOI: 10.1007/s00784-026-06894-9 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Oral Investigations, online erschienen am 02.05.2026. Verfasst von Bo Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial-Head and Neck Oncology, Beijing Stomatological Hospital, Capital Medical University, Beijing, 100070, P.R. China. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Mouth Neoplasms. Die Arbeit nennt 23 Literaturangaben. Gefördert von: Young Scientist Program of Beijing Stomatological Hospital, Capital Medical University, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: This study aimed to identify a subset of patients with pN1 oral squamous cell carcinoma (OSCC) and no adverse pathological features who derive significant benefit from adjuvant radiotherapy (RT). MATERIALS AND METHODS: In this multicenter retrospective study, 232 eligible pN1 OSCC patients were analyzed. Patients were stratified by T-stage (T1-2 vs. T3-4) and lymph node yield (LNY; high: ≥20; low:

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Squamous CellMouth NeoplasmsHumansRetrospective StudiesRadiotherapy, AdjuvantNeoplasm StagingFemaleMaleLymphatic MetastasisMiddle AgedAgedPredictive Value of TestsSurvival RateLymph NodesPrognosis

Stichwörter der Autor:innen

Lymph node yieldOSCCRadiotherapyT-stagepN1

Autor:innen und Institutionen

  • Department of Oral and Maxillofacial-Head and Neck Oncology, Beijing Stomatological Hospital, Capital Medical University, Beijing, 100070, P.R. China.
  • Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing, 100081, P.R. China.
  • Clinical Epidemiology and EBM Unit, National Clinical Research Center for Digestive Diseases, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, PR China.
  • Department of Oral and Maxillofacial & Head and Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, P.R. China. caowei561521@shsmu.edu.cn.
  • Department of Oral and Maxillofacial-Head and Neck Oncology, Beijing Stomatological Hospital, Capital Medical University, Beijing, 100070, P.R. China. jyfzhen@mail.ccmu.edu.cn.

Förderung

  • Young Scientist Program of Beijing Stomatological Hospital, Capital Medical University
  • National Natural Science Foundation of China

Zitieren

APA

Li, B., Huang, Y., Zhou, H., Guo, C., Wei, W., Cao, W., & Feng, Z. (2026). Synergistic predictive value of T-stage and lymph node yield in guiding adjuvant radiotherapy decisions for pN1 OSCC without high-risk features: a multi-institutional retrospective cohort study. Clinical Oral Investigations, 30(5). https://doi.org/10.1007/s00784-026-06894-9

Vancouver

Li B, Huang Y, Zhou H, Guo C, Wei W, Cao W, et al. Synergistic predictive value of T-stage and lymph node yield in guiding adjuvant radiotherapy decisions for pN1 OSCC without high-risk features: a multi-institutional retrospective cohort study. Clinical Oral Investigations. 2026;30(5). doi:10.1007/s00784-026-06894-9

BibTeX
@article{Li2026,
  author = {Li, Bo and Huang, Yu and Zhou, Hanchen and Guo, Chuanbin and Wei, Wei and Cao, Wei and Feng, Zhien},
  title = {Synergistic predictive value of T-stage and lymph node yield in guiding adjuvant radiotherapy decisions for pN1 OSCC without high-risk features: a multi-institutional retrospective cohort study},
  journal = {Clinical Oral Investigations},
  year = {2026},
  volume = {30},
  number = {5},
  doi = {10.1007/s00784-026-06894-9}
}
Kostenlos starten →